VoluMetrix Awarded Grant from Center for Advancing Point of Care Technologies (CAPCaT) to accelerate validation of NIVA|HF
Nashville, Tenn. (PRWEB) March 30, 2023 -- VoluMetrix, a Nashville-based biotech startup dedicated to creating a new wave of solutions for vital monitoring, announced today that it has been awarded a grant from the Center for Advancing Point of Care Technologies (CAPCaT) in Heart, Lung, Blood, and Sleep Disorders, to accelerate the validation of NIVA|HF, a device designed to provide volume status monitoring non-invasively for heart failure patients.
“We are thrilled to receive this award and partner with CAPCaT to accelerate the validation of our device. Our goal to provide a personalized solution for heart failure patients,” said Kyle Hocking, Ph.D., President & CEO of VoluMetrix.
Heart failure affects more than six million Americans and is the most common reason for hospitalization of elderly patients. Current heart failure monitoring is inadequate with over 90 percent of patients monitored by clinical symptoms and weights, which are late and unreliable indicators. Monitoring cardiac filling pressures is the gold standard in heart failure, but this requires invasive procedures or implanted devices. VoluMetrix has developed the investigational NIVA|HF device, a remote monitoring technology worn on the wrist, designed to provide non-invasive, real-time estimates of cardiac filling pressure from hospital to home.
CAPCaT, a partnership between UMass Chan Medical School and UMass Lowell, is a product of the institutions’ joint venture, the Massachusetts Medical Device Development Center (M2D2). M2D2 was established with a core mission to support promising late-stage point of care technologies.
“We’re pleased to support the VoluMetrix team and the development of its NIVA technology, which aims to allow heart-failure patients the chance to monitor their circulatory system’s health in a safe and noninvasive way,” said Bryan Buchholz, CAPCaT co-director and UMass Lowell Biomedical Engineering Professor Emeritus. “The technology is just the latest example of CAPCaT’s mission to improve the quality of health care for patients coping with heart, lung, blood and sleep disorders.
“The CAPCaT collaboration between UMass Chan and UMass Lowell is among the most gratifying partnerships I’m involved in,” said CAPCaT co-director David McManus, MD, the Richard M. Haidack Professor of Medicine and chair and professor of medicine, Dr. McManus, the founding director of the Program in Digital Medicine added, “The VoluMetrix technology shows great promise for countless patients who are partnering with their doctors to control their own well-being.”
What is NIVA Technology?
NIVA is a proprietary venous waveform technology from VoluMetrix, representing a major innovation in vital monitoring technology. The venous waveform is an energy-based signal generated by the heart and respiratory activity that reflects numerous physiologic conditions, including pulse rate and respiration, as well as intravascular and extravascular dynamics. NIVA was developed to optimize hemodynamic assessment in three key ways: signal capture (using a non-invasive wrist sensor), signal deconstruction (mapping individual amplitudes within a patient's waveform), and signal decoding.
About VoluMetrix
VoluMetrix is a Nashville-based company that is dedicated to creating a new wave of solutions for vital monitoring to enhance well-being. As pioneers of non-invasive venous waveform technology, we are partnering closely with patients and practitioners to develop the pathway towards the optimal implementation and utilization of our technology, from hospital to home.
NIVA technology is investigational and is not available for sale in the United States.
Research and development reported in this press release was supported by the National Heart, Lung and Blood Institute of the National Institutes of Health under award number, R44HL140669. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.
For more information, please visit our website at https://www.volumetrix.com.
Annie Alvis, VoluMetrix, http://www.volumetrix.com, 1 (615) 219-9536, [email protected]
Share this article